The Food and Drug Administration's oncologic drugs advisory committee on voted against approval of GSK's blood cancer drug Blenrep. The British pharmaceutical company said Thursday combinations for ...

GSK is witnessing increased sales growth of its Specialty Medicines unit, a trend expected to continue through the rest of 2025.

GSK stock is up 21.5% in six months, fueled by strong Specialty Medicines growth and a promising pipeline despite vaccine headwinds.

Antibody-Drug Conjugates (ADC) Market- Driven by Advanced Payload Technologies and Strategic Industry Partnerships Sai Kumar DataM Intelligence 4market Research LLP +1 877-441-4866 ... Visit us on ...

FDA advisers on Thursday voted against GSK's blood cancer drug Blenrep, finding that its risks outweighed its benefits at the ...

WASHINGTON, June 20 (Reuters) - Japan has canceled an annual high-level meeting with key ally the United States after the Trump administration demanded it spend more on defense, the Financial ...

Planning your first trip to Japan? These essential travel tips cover everything from etiquette to apps—what to know before you go in 2025.

GSK confirmed this morning that the disappointing readout from the DREAMM-3 trial of multiple myeloma therapy Blenrep reported earlier this month means that it will take the drug off the US market.

The FDA has approved GlaxoSmithKline’s multiple myeloma drug Blenrep, a first-in-class potential blockbuster that will be used in advanced disease.

Japan has condemned US President Donald Trump for comparing recent US strikes on Iran to the bombing of Hiroshima and Nagasaki that ended World War II.

View the latest weather forecasts, maps, news and alerts on Yahoo Weather. Find local weather forecasts for Tokyo, Japan throughout the world ...

Use our currency converter to find the live exchange rate between JPY and USD. Convert Japanese Yen to United States Dollar ...